CROI 2013: Updates on the Treatment of Hepatitis C (Video)
March 14, 2013
In particular, one of the studies showed 100% sustained viral response rates using sofosbuvir, ledipasvir and ribavirin for both treatment-naive patients and non-responders (patients who had tried interferon in the past but had poor response).
Additionally, they discussed a study looking at faldaprevir and simeprevir in HIV/hepatitis C-coinfected patients, which showed almost identical results to what has been seen in hepatitis C-monoinfected patients. This finding suggests that perhaps HIV coinfection won't be a barrier to curing hepatitis C, especially with these newer, direct-acting antivirals.
While the study sizes were small, the findings do show hope for more effective treatment and curing of hepatitis C, without the use of interferon.
More on the three panelists convened by Liz Highleyman:
The video above has been cross-posted on TheBodyPRO.com with permission from our partners at the International Foundation for Alternative Research in AIDS (IFARA). Visit IFARA's website to watch more video interviews from the conference, as well as earlier meetings.
CROI 2013: The Latest on HIV Drugs in Development, Antiretroviral Strategy and Treatment as Prevention (Video)
This article was provided by International Foundation for Alternative Research in AIDS.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)